Tiziana Life Sciences Ltd
TLSA
$0.81
$0.00991.24%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.60% | 9.97% | -14.90% | -41.36% | -78.68% |
| Total Depreciation and Amortization | 1.98% | 30.92% | 88.24% | 22.36% | -8.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.45% | 356.32% | 212.05% | 176.48% | 162.27% |
| Change in Net Operating Assets | 216.73% | 165.10% | -35.91% | -67.97% | -83.04% |
| Cash from Operations | 79.54% | 49.36% | 19.97% | 14.44% | 9.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99,900.00% | 25.29% | 62.63% | 80.75% | 99.96% |
| Cash from Investing | -101,300.00% | 24.77% | 62.63% | 80.75% | 99.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -64.13% | -83.67% | -116.36% | -1.93% | 39.47% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 87.82% | 80.76% | 52.07% | 5.20% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -66.42% | -- |
| Cash from Financing | 101.05% | 90.86% | 84.51% | 44.59% | -53.76% |
| Foreign Exchange rate Adjustments | -14.17% | 34.01% | 92.96% | 79.47% | 76.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 200.00% | 200.00% |
| Net Change in Cash | 72.59% | 49.09% | 29.61% | 27.39% | 25.40% |